Sangamo Therapeutics Inc (OQ:SGMO)

Business Focus: Bio Therapeutic Drugs

Latest 10 SEC filings (by transaction date) for SGMO within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET August 24th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Aug 14/19 Aug 12/19 Boissel Stephane Direct Ownership Free Shares Put Option (right to sell to Issuer) M - Exercise or conversion exempt under rule 16b-3 -1  
Aug 14/19 Aug 12/19 Boissel Stephane Direct Ownership Common Stock D - Disposition to issuer under Rule 16b-3(e) -11,137 $11.23
Aug 14/19 Aug 12/19 Boissel Stephane Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 11,137  
Jun 18/19 Jun 18/19 Duraibabu Prathyusha Direct Ownership Stock Option (Right to Buy) Form 3 : Initial Statement of Beneficial Ownership of Securities    
Jun 18/19 Jun 18/19 Duraibabu Prathyusha Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Jun 12/19 Jun 10/19 Zakrzewski Joseph S Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 15,000  
Jun 12/19 Jun 10/19 Zakrzewski Joseph S Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 2,500  
Jun 12/19 Jun 10/19 Smith Karen L. Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 15,000  
Jun 12/19 Jun 10/19 Smith Karen L. Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 2,500  
Jun 12/19 Jun 10/19 Ramasastry Saira Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 15,000  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for SGMO within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET August 24th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Aug 14/19 Aug 12/19 Boissel Stephane Direct Ownership Free Shares Put Option (right to sell to Issuer) M - Exercise or conversion exempt under rule 16b-3 -1  
Aug 14/19 Aug 12/19 Boissel Stephane Direct Ownership Common Stock D - Disposition to issuer under Rule 16b-3(e) -11,137 $11.23
Aug 14/19 Aug 12/19 Boissel Stephane Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 11,137  
Aug 14/19 Nov 27/18 Boissel Stephane Direct Ownership Free Shares Put Options (right to sell to Issuer) J - Other transaction 4  
Aug 14/19 Nov 27/18 Boissel Stephane Direct Ownership Free Shares Call Options (obligation to sell to Issuer) J - Other transaction -4  
Jun 18/19 Jun 18/19 Duraibabu Prathyusha Direct Ownership Stock Option (Right to Buy) Form 3 : Initial Statement of Beneficial Ownership of Securities    
Jun 18/19 Jun 18/19 Duraibabu Prathyusha Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Jun 12/19 Jun 10/19 Zakrzewski Joseph S Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 15,000  
Jun 12/19 Jun 10/19 Zakrzewski Joseph S Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 2,500  
Jun 12/19 Jun 10/19 Smith Karen L. Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 15,000  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $SGMO

StockTwits